Brief: Egetis Therapeutics Chairman Bought Co Shares
Nov 27 (Reuters) - Finansinspektionen: CHAIRMAN OF EGETIS THERAPEUTICS BOARD MATS BLOM ACQUIRED SEK 943,200 WORTH OF CO'S SHARE ON NOV 25TH-FINANSINSPEKTIONEN Further company coverage: EGTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1